Infectious Bronchitis (Avian Infectious Bronchitis Virus - IBV)

Infectious Bronchitis (IB) is a highly contagious, acute, and economically devastating viral disease of chickens caused by the Avian Infectious Bronchitis Virus (IBV), a member of the genus Gammacoronavirus within the family Coronaviridae. The disease primarily affects the respiratory tract, but nephropathogenic strains cause severe renal damage, and some strains exhibit tropism for the reproductive tract, leading to permanent egg production and quality losses in layers and breeders. IBV is characterized by rapid onset, high morbidity (approaching 100%), and variable mortality depending on strain virulence, age, and secondary infections. In broilers, IB results in poor weight gain, increased feed conversion ratio (FCR), and increased condemnations at processing due to airsacculitis and cellulitis. In commercial layers and breeders, the disease causes a dramatic drop in egg production (up to 70%) and the production of misshapen, soft-shelled, and pale eggs. The virus is enveloped, with a single-stranded positive-sense RNA genome of approximately 27.6 kb, and exhibits a high mutation rate, leading to numerous serotypes and genotypes worldwide. The Massachusetts (Mass) serotype is the classic and most widespread, but variants such as Arkansas (Ark), Delaware (DE072), Georgia 98 (GA98), and California (CAL) have emerged, complicating control. IBV is distributed globally, affecting all poultry sectors, including broilers, commercial layers, broiler breeders, and backyard flocks. Turkeys and ducks are generally resistant to clinical disease, but experimental infection can occur. The disease is a major concern for the poultry industry due to its impact on animal welfare, production efficiency, and international trade restrictions.

The etiological agent is Avian Infectious Bronchitis Virus (IBV), a gammacoronavirus. The virion is pleomorphic, roughly spherical, 80-120 nm in diameter, with a lipid envelope studded with club-shaped spike (S) glycoproteins. The S protein is cleaved into S1 and S2 subunits; S1 contains major neutralizing and serotype-specific epitopes, while S2 anchors the spike to the envelope. The genome also encodes the membrane (M) protein, envelope (E) protein, and nucleocapsid (N) protein. The N protein is highly conserved and used for group-specific diagnostics. IBV exhibits extensive genetic and antigenic diversity due to high mutation rates and recombination events, particularly in the S1 gene. Numerous serotypes exist, including Mass, Connecticut (Conn), Arkansas (Ark), Delaware (DE072), Georgia 98 (GA98), California (CAL), and many others. Nephropathogenic strains (e.g., Australian T strain, Holte, Gray) cause severe interstitial nephritis and ureter distension. Variant strains often emerge due to vaccine pressure and recombination, leading to vaccine breaks. The virus is inactivated by heat (56°C for 15 minutes), lipid solvents (ether, chloroform), and common disinfectants (phenols, formalin, quaternary ammonium compounds). It survives in organic material for days to weeks, especially in cool, moist environments.

Infectious Bronchitis affects chickens of all ages, but clinical disease is most severe in young chicks (under 6 weeks) and in laying hens. Broilers are commonly affected, leading to respiratory distress, increased mortality (2-10% in uncomplicated cases, higher with secondary infections), and poor performance. In commercial layers and breeders, the primary impact is a severe drop in egg production (up to 70%) and egg quality deterioration, which may be permanent if infection occurs before peak production. The disease is highly contagious, spreading rapidly via aerosol, direct contact, and contaminated fomites (feed, water, equipment, personnel). The incubation period is 18-36 hours. Morbidity is typically 100% within 2-3 days of exposure. Mortality varies: in broilers, it ranges from 0-25% depending on strain and secondary infections; in layers, mortality is usually low (<5%) but can be higher with nephropathogenic strains. The virus replicates in the respiratory tract, then viremia leads to infection of the kidney, oviduct, and other tissues. Transmission is primarily horizontal; vertical transmission is not significant. Risk factors include high stocking density, poor ventilation, high ammonia levels, concurrent infections (e.g., Mycoplasma gallisepticum, Escherichia coli), and immunosuppression (e.g., infectious bursal disease virus). Seasonality is less pronounced in intensive systems, but outbreaks may increase in cooler months due to reduced ventilation. Wild birds are not significant reservoirs, but fomites and contaminated litter can carry the virus. Biosecurity lapses, including movement of personnel and equipment between flocks, are common causes of spread.

IBV enters the host via the respiratory route, attaching to ciliated epithelial cells of the trachea, nasal passages, and lungs via the S1 spike protein. The virus replicates in these cells, causing ciliary stasis, loss of cilia, and epithelial necrosis. This leads to respiratory signs and predisposes to secondary bacterial infections. Within 24-48 hours, viremia occurs, and the virus spreads to other tissues, including the kidney, oviduct, and gastrointestinal tract. Nephropathogenic strains cause severe interstitial nephritis, tubular necrosis, and urate accumulation in the ureters and kidneys, leading to renal failure and increased mortality. In the oviduct, infection of the magnum and shell gland results in decreased albumen secretion and abnormal eggshell formation, leading to egg production drops and misshapen eggs. The virus also replicates in the bursa of Fabricius, thymus, and spleen, causing lymphoid depletion and immunosuppression. The immune response involves both humoral (neutralizing antibodies) and cell-mediated immunity, but protection is serotype-specific. The virus can persist in the cecal tonsils and kidneys for weeks, leading to intermittent shedding. Histopathologically, the trachea shows loss of cilia, epithelial hyperplasia, and infiltration of mononuclear cells. In the kidney, there is interstitial nephritis with lymphocytic infiltration and tubular degeneration. In the oviduct, there is glandular degeneration and fibrosis, which may be permanent if infection occurs early in life.

Intrinsic factors include age (young chicks are more susceptible to severe respiratory disease), genetic strain (some lines are more resistant), immune status (maternal antibody interference, immunosuppression), and high production stress in layers. Extrinsic factors include poor biosecurity (allowing introduction of the virus), high stocking density, inadequate ventilation leading to high ammonia and humidity, wet litter, poor feed quality (e.g., mycotoxins), and vaccination failure due to improper handling, administration, or serotype mismatch. Concurrent infections with Mycoplasma gallisepticum, Escherichia coli, or infectious bursal disease virus exacerbate the severity of IB. Environmental stress, such as temperature fluctuations and poor nutrition, also increase susceptibility.

Clinical signs vary with age, strain, and secondary infections. In broilers and young chicks, signs include depression, huddling, ruffled feathers, gasping, coughing, sneezing, tracheal rales, and nasal discharge. Ocular discharge and facial edema may occur. In layers, respiratory signs may be mild, but the primary signs are a sudden drop in egg production (up to 70%) and the production of soft-shelled, misshapen, rough-shelled, and pale eggs. Egg albumen becomes watery, and shell quality deteriorates. In nephropathogenic infections, signs include increased water consumption, wet droppings, and depression, with mortality up to 25% in young birds. Some strains cause swelling of the head and wattles. In severe cases, cyanosis of the comb and wattles may be observed. Neurological signs are rare but can occur with some variant strains. The disease course is typically 1-2 weeks, but egg production may take several weeks to recover, and in some cases, production never returns to normal.

Differential diagnoses include: 1) Newcastle Disease (ND): Caused by avian paramyxovirus type 1, ND causes similar respiratory signs but also neurological signs (torticollis, paralysis) and gastrointestinal lesions (hemorrhagic ulcers). ND is more severe with higher mortality. Diagnosis via virus isolation, RT-PCR, and HI test. 2) Avian Influenza (AI): Caused by influenza A viruses, AI can cause respiratory signs, depression, and sudden death. Highly pathogenic AI (HPAI) causes severe systemic disease with cyanosis and hemorrhages. Diagnosis via virus isolation, RT-PCR, and AGID. 3) Infectious Laryngotracheitis (ILT): Caused by gallid herpesvirus 1, ILT causes severe respiratory distress, gasping, and expectoration of bloody mucus. Lesions include tracheitis with intranuclear inclusion bodies. Diagnosis via virus isolation, PCR, and histopathology. 4) Mycoplasmosis (Mycoplasma gallisepticum): Causes chronic respiratory disease with rales, coughing, and airsacculitis. Diagnosis via serology (ELISA, HI), PCR, and culture. 5) Infectious Coryza (Avibacterium paragallinarum): Causes facial edema, nasal discharge, and conjunctivitis. Diagnosis via bacterial culture and PCR. 6) Aspergillosis: Fungal infection causing respiratory distress, gasping, and granulomatous lesions in lungs and air sacs. Diagnosis via histopathology and culture. 7) Vitamin A Deficiency: Causes respiratory epithelial metaplasia and ocular discharge. Diagnosis via history, necropsy, and feed analysis. 8) Coccidiosis: Intestinal disease causing diarrhea and poor performance, but not respiratory signs. Diagnosis via fecal floatation and lesion scoring.

The diagnostic approach begins with flock history and clinical signs, especially sudden respiratory distress and egg production drops. Perform a thorough necropsy of representative birds, examining the trachea for mucus, congestion, and caseous exudate; the kidneys for swelling and urate deposition; and the oviduct for abnormalities. Collect samples for laboratory testing: tracheal swabs, kidney tissue, and oviduct tissue for RT-PCR and virus isolation. Serology: collect paired serum samples (acute and convalescent) for ELISA or HI test to demonstrate a rise in antibody titers. For virus isolation, inoculate embryonated chicken eggs (SPF) via the allantoic cavity; embryo stunting and curling are characteristic. Confirm with RT-PCR targeting the S1 gene and sequencing for genotyping. Histopathology of trachea, kidney, and oviduct can reveal characteristic lesions. Differential diagnosis should rule out ND, AI, ILT, and mycoplasmosis. A definitive diagnosis is based on virus isolation or PCR, supported by seroconversion.

Serology: ELISA is commonly used to detect antibodies; a significant rise in titer (4-fold) between acute and convalescent samples indicates recent infection. HI test using specific serotypes can identify the infecting serotype. AGID is less sensitive but can detect group-specific antibodies. Molecular Diagnostics: RT-PCR targeting the S1 gene is highly sensitive and specific; real-time RT-PCR can quantify viral load. Sequencing of the S1 gene allows genotyping and comparison with vaccine strains. Microbiology: Bacterial culture of tracheal and lung samples may reveal secondary pathogens such as E. coli. Mycoplasma culture and PCR are important to rule out co-infection. Hematology: Blood chemistry may show elevated uric acid and creatinine in nephropathogenic cases. Coccidiosis lesion scoring is not directly relevant but may be performed if coccidiosis is suspected as a concurrent issue.

Radiography is not commonly used in poultry, but in cases of nephropathogenic IB, it may show renomegaly and urolithiasis. Ultrasonography is rarely used. Gross necropsy photography is essential for documentation: tracheal congestion and mucus, kidney swelling with urate deposits, and oviduct regression or cysts in layers. Imaging hallmarks include the characteristic 'curled embryo' in eggs used for virus isolation.

Gross necropsy findings: Tracheitis with excess mucus, congestion, and sometimes caseous exudate. In nephropathogenic cases, kidneys are swollen, pale, and have distended ureters filled with urates. In layers, the oviduct may be regressed, cystic, or contain caseous material. Airsacculitis and peritonitis may be present due to secondary E. coli. Histopathology: Tracheal epithelium shows loss of cilia, necrosis, and hyperplasia; submucosa is edematous with mononuclear infiltration. In the kidney, interstitial nephritis with lymphocytic infiltration, tubular degeneration, and casts. In the oviduct, glandular degeneration and fibrosis. In the bursa of Fabricius, lymphoid depletion. Inclusion bodies are not typical for IBV, but syncytia may be seen in tracheal epithelium.

There is no specific antiviral treatment for IB. Management focuses on supportive care and control of secondary infections. Antibiotics (e.g., oxytetracycline, tylosin, enrofloxacin where legal) are administered in drinking water to prevent or treat secondary bacterial infections. For example, oxytetracycline at 10-20 mg/kg body weight per day, or tylosin at 25 mg/kg, or enrofloxacin at 10 mg/kg (where approved). Supportive therapy includes vitamins and electrolytes (e.g., vitamin A, vitamin C, and electrolytes) to reduce stress and support recovery. In layers, increasing the amount of vitamin D3 and calcium in the diet may help improve eggshell quality. Biosecurity measures should be enhanced to prevent spread. Vaccination is the primary control method: live attenuated vaccines (e.g., Mass type) are administered via spray, drinking water, or eye-drop to chicks at 1 day of age, with boosters at 2-4 weeks. Inactivated vaccines are used in layers and breeders to boost immunity. However, vaccine breaks can occur due to variant strains, so autogenous vaccines may be considered. In severe outbreaks, depopulation may be necessary for virulent strains, but this is not common.

The prognosis is generally good for uncomplicated cases, with recovery in 1-2 weeks. However, mortality can be high in young chicks with nephropathogenic strains (up to 25%). In layers, egg production may take 4-6 weeks to recover, but it may not return to pre-infection levels, especially if infection occurs before peak production. Permanent damage to the oviduct can lead to reduced egg production and quality. In broilers, FCR may be permanently increased, and processing condemnations due to airsacculitis may occur. The flock may be immunosuppressed, increasing susceptibility to other diseases. The prognosis is worse in flocks with poor management, high stress, or concurrent infections.

After an outbreak, monitor the flock for 2-4 weeks for clinical signs and egg production recovery. Conduct serological monitoring (ELISA) every 2-4 weeks to assess antibody levels and ensure adequate immunity. Review and improve biosecurity protocols, including cleaning and disinfection of facilities, equipment, and personnel movement. Litter management should be optimized to reduce ammonia and moisture. For layers, monitor egg quality and production parameters. In pullet rearing, ensure vaccination programs are adjusted to match circulating strains. Conduct a post-outbreak audit to identify lapses in biosecurity and implement corrective actions.

Pearls: 1) In layers, a sudden drop in egg production with misshapen eggs is highly suggestive of IB. 2) Nephropathogenic IB should be suspected in young chicks with increased water intake and wet litter. 3) Tracheal rales are often the first clinical sign in broilers. 4) The bursa of Fabricius is not typically affected in IB, unlike IBD. 5) Vaccination with live Mass type provides good cross-protection against many variants, but not all. Pitfalls: 1) Confusing IB with ND or AI; always rule out these reportable diseases. 2) Assuming that vaccination guarantees protection; vaccine breaks are common due to variant strains. 3) Neglecting secondary bacterial infections, which can worsen the disease. 4) Using the wrong serotype in vaccines. 5) Failing to implement strict biosecurity, leading to rapid spread.

Antibiotics for secondary bacterial infections: Amoxicillin: 10-20 mg/kg body weight orally, or 100-200 mg/L drinking water for 3-5 days. Oxytetracycline: 10-20 mg/kg, or 100-200 mg/L drinking water for 3-5 days. Tylosin: 25 mg/kg, or 500 mg/L drinking water for 3-5 days. Tilmicosin: 15-20 mg/kg, or 75 mg/L drinking water for 3 days (not for use in layers producing eggs for human consumption). Enrofloxacin: 10 mg/kg, or 50-100 mg/L drinking water for 3-5 days (where legal). Florfenicol: 20-30 mg/kg, or 400 mg/L drinking water for 3-5 days. Supportive vitamins: Vitamin A: 10,000-20,000 IU/kg feed; Vitamin D3: 2,000-4,000 IU/kg feed; Vitamin E: 100-200 mg/kg feed; Vitamin C: 100-200 mg/L drinking water; Vitamin K: 2-5 mg/kg feed. Electrolytes: 0.5-1% glucose and electrolytes in drinking water. Vaccines: Live IB vaccines (Mass, Ark, DE072, etc.) are given at 1 day of age via spray or eye-drop, and boosted at 2-4 weeks via drinking water. Inactivated vaccines are given to layers and breeders at 16-18 weeks subcutaneously. Dosages per label instructions. Withdrawal times must be observed for antibiotics.

Landmark studies have demonstrated the efficacy of live attenuated IB vaccines in reducing clinical signs and mortality, but variant strains continue to emerge, necessitating the use of autogenous vaccines. A meta-analysis of field trials showed that vaccination with Mass type reduces egg production losses by up to 50%. Studies on nephropathogenic strains have highlighted the importance of supportive care and hydration. The AAAP and WVPA consensus guidelines recommend a comprehensive biosecurity program and vaccination strategy tailored to the local serotypes. Research on the molecular epidemiology of IBV has identified recombination events as a major source of new variants. Experimental studies have shown that the S1 protein is the major immunogen, and cross-protection is correlated with S1 sequence similarity. Field trials have demonstrated that early vaccination (1 day of age) with live vaccines is effective in broilers, but maternal antibodies can interfere. Overall, the literature emphasizes the need for continuous surveillance and adaptation of control measures.